ABOUT HASTEN BIOPHARMA

About Hasten Biopharma

ROOTED IN CHINA, THINKING GLOBALLY

Scroll down

Hasten Biopharma Co. Ltd. (Hasten), which integrates R&D, production and commercial promotion and covers the whole industrial chain, was established in 2020. Hasten is jointly invested and established by CBC Group, one of the largest healthcare-dedicated investment firms in Asia, Hefei Industry Investment Group and Feidong County, Hefei City.

Rooted in China with a global perspective, Hasten will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization", as well as enrich product structure and pipelines by virtue of diversified ways and relying on the broad medical and health platform and resources of CBC Group. We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases and geriatric-related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients.

6 offices
600+ talents
1 Million+ patients covered

CEO MESSAGE

Summer XIA - CEO of Hasten Biopharma

In less than 2 years since it was established, Hasten Biopharma quickly owned the commercialization rights of 5 originator drugs in China and built a team of over 600 people. In the future, Hasten Biopharma will continue to maintain a rapid development trend, follow the pulse of the times, rooted in China while looking at the world, through the "whole industry" and "globalization" layout, connecting the upstream and downstream industry chain, with a diversified approach to enrich our product portfolio and product pipeline, to achieve the goal of meeting the needs of healthcare professionals and patients, to create our own era of highlight.

With a well-established commercialization marketing network and professional marketing team, Hasten Biopharma is like a ship flying forward. We will strive to move forward in the blue ocean of health care by the ship of doctor-patient service, taking human health as the shore, innovation as the paddle, forging ahead as the sail.

OUR CULTURE

VISION

VISION

Establish professional talent team

Provide high-quality treatment solutions

Build health management ecosystem

Be leader in the healthcare industry
MISSION

MISSION

Hospital-patient needs first

Strive for excellence and perfection

Serve the human health
VALUE

VALUE

Integrity

Agility

Innovation

Ownership
AMBITIONS

AMBITIONS

In the future, the unmet medical needs in the field of chronic diseases and geriatric related diseases will be growing and generate large marketing potentials.

Rooted in China with a global perspective, Hasten will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization", as well as enrich product structure and pipelines by virtue of diversified ways and relying on the broad medical and health platform and resources of CBC Group.

We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases and geriatric-related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients.